Otofarma S.P.A. Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Revenue	14.33	10.12
Other Revenue	0.05	0.01
Revenue	14.38	10.13
Revenue Growth	42.00%	-
Cost of Revenue	9.7	7.93
Gross Profit	4.69	2.2
Selling, General & Admin	1.14	0.86
Amortization of Goodwill & Intangibles	0.07	-
Other Operating Expenses	0.24	0.03
Operating Expenses	1.5	0.95
Operating Income	3.19	1.25
Interest Expense	-0.11	-0.1
Currency Exchange Gain (Loss)	-	0
Other Non Operating Income (Expenses)	0	-
Pretax Income	3.08	1.15
Income Tax Expense	0.98	0.39
Net Income	2.1	0.75
Net Income to Common	2.1	0.75
Net Income Growth	178.25%	-
Free Cash Flow	2.01	0.39
Gross Margin	32.60%	21.68%
Operating Margin	22.16%	12.34%
Profit Margin	14.60%	7.45%
Free Cash Flow Margin	13.98%	3.86%
EBITDA	3.25	1.3
EBITDA Margin	22.57%	12.88%
D&A For EBITDA	0.06	0.05
EBIT	3.19	1.25
EBIT Margin	22.16%	12.34%
Effective Tax Rate	31.77%	34.33%
Revenue as Reported	14.49	10.45